Perfromance Wealth Partners LLC cut its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 0.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 11,229 shares of the financial services provider’s stock after selling 100 shares during the period. Perfromance Wealth Partners LLC’s holdings in CME Group were worth $3,095,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of CME. GAMMA Investing LLC lifted its position in CME Group by 24.5% during the first quarter. GAMMA Investing LLC now owns 7,007 shares of the financial services provider’s stock valued at $1,859,000 after purchasing an additional 1,381 shares in the last quarter. Stock Yards Bank & Trust Co. bought a new position in shares of CME Group in the first quarter worth about $210,000. Wealth Enhancement Advisory Services LLC lifted its position in shares of CME Group by 63.0% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 105,044 shares of the financial services provider’s stock valued at $27,867,000 after buying an additional 40,592 shares in the last quarter. Dynamic Advisor Solutions LLC grew its stake in shares of CME Group by 3.1% during the 1st quarter. Dynamic Advisor Solutions LLC now owns 2,533 shares of the financial services provider’s stock valued at $672,000 after acquiring an additional 76 shares during the period. Finally, Ritholtz Wealth Management grew its stake in shares of CME Group by 10.3% during the 1st quarter. Ritholtz Wealth Management now owns 4,451 shares of the financial services provider’s stock valued at $1,181,000 after acquiring an additional 416 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Stock Down 0.1%
Shares of CME stock opened at $271.28 on Tuesday. The company’s fifty day simple moving average is $268.57 and its two-hundred day simple moving average is $271.35. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79. The stock has a market cap of $97.76 billion, a P/E ratio of 26.26, a PEG ratio of 5.72 and a beta of 0.41. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s payout ratio is presently 48.40%.
Analyst Ratings Changes
CME has been the topic of a number of recent analyst reports. Morgan Stanley raised their target price on shares of CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 1st. Barclays dropped their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a report on Wednesday, October 8th. Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Deutsche Bank Aktiengesellschaft lowered their price objective on CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a research report on Thursday, October 9th. Finally, TD Cowen increased their target price on CME Group from $281.00 to $288.00 and gave the stock a “hold” rating in a research report on Wednesday, October 8th. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and an average price target of $283.43.
Read Our Latest Stock Analysis on CME Group
Insider Transactions at CME Group
In other news, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William R. Shepard bought 262 shares of the business’s stock in a transaction that occurred on Thursday, September 25th. The stock was acquired at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the acquisition, the director owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Insiders sold 13,043 shares of company stock valued at $3,527,956 over the last 90 days. Insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- What is a Death Cross in Stocks?
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- How to Short Nasdaq: An Easy-to-Follow Guide
- Datavault: A Speculative AI Play, But Beware of Volatility
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.